[REVISION HISTORY]
2026/2027 influenza vaccination rollout
14 recorded revisions of this situation.
What changed
2026-11-11 07:00 UTC → 2026-11-16 16:24 UTC ·
added
removed
For the 2026/2027 influenza season, health authorities have updated vaccine compositions to align with World Health Organization guidelines. In the Czech Republic, the National Institute of Public Health (SZÚ) noted that all three viral strains in the trivalent vaccine have changed, including two Type A variants and one Type B variant. New vaccines include the K subclade (J.2.4.1) of the A(H3N2) virus. In Romania, the vaccination campaign has commenced with various compensation levels for different demographics. In North Macedonia, health authorities report robust interest, with over 66,000 citizens registered since October 14. Health Minister Sasho Klevkoski reported a vaccination rate of approximately 1,000 people per day. To meet demand, the government secured 26,000 additional doses from Sanofi, bringing the total available supply to 56,000, with another 30,000 expected by late November. In Bulgaria, supply challenges persist. While 150,000 doses arrived for national programs, a shortage of injectable doses for the open market has been reported. Health Minister Katya Ivkova informed Parliament that previously attributed delays are primarily due to operational difficulties in filling and packaging processes, packaging, the complexity of incorporating new strains, and the late determination of the influenza B virus type. Swiss Biopharma reported delivering 150,000 doses by October 21, including 100,000 doses of Vaxigrip and 50,000 doses of Efluelda. Addressing concerns regarding To address shortages in pharmacies and the National Prevention Program, Minister Ivkova announced that influenza vaccines are were expected to be delivered by the end of the week. Furthermore, the The Ministry of Health also presented a draft budget for next year totaling approximately 725 million euros, which includes a 70 percent increase in immunization funding. Regarding the open market, Bulgaria is set to receive 40,000 doses of the Vaxigrip vaccine for pharmacy sale following quality checks by Suix Biopharma. An additional 30,000 doses are expected by the end of November, requiring packaging adaptation for the local market. This brings the total expected for the free market in November to 70,000 doses.
Versions
- 2026-11-16 16:24 UTC 2026/2027 influenza vaccination rollout
- 2026-11-11 07:00 UTC 2026/2027 influenza vaccination rollout
- 2026-11-08 13:15 UTC 2026/2027 influenza vaccination rollout
- 2026-10-28 14:27 UTC 2026/2027 influenza vaccination rollout
- 2026-10-28 13:54 UTC 2026/2027 influenza vaccination rollout
- 2026-10-27 10:26 UTC 2026/2027 influenza vaccination rollout
- 2026-10-19 19:48 UTC 2026/2027 influenza vaccination rollout
- 2026-10-18 06:26 UTC 2026/2027 influenza vaccination rollout
- 2026-10-17 09:25 UTC 2026/2027 influenza vaccination rollout
- 2026-10-16 14:20 UTC 2026/2027 influenza vaccination rollout
- 2026-10-15 09:01 UTC 2026/2027 influenza vaccination rollout
- 2026-10-03 07:36 UTC 2026/2027 influenza vaccination rollout
- 2026-09-30 02:53 UTC 2026/2027 influenza vaccination rollout
- 2026-09-28 07:31 UTC 2026/2027 influenza vaccination rollout
- 2026-09-19 10:05 UTC 2026/2027 influenza vaccination rollout
Select a version to see what changed compared to the one before it.